Assessment of psychoeducational outcomes after pediatric liver transplant

S Gilmour1, R Adkins, G A Liddell

  • 1Department of Pediatrics, Stollery Children's Hospital, Edmonton, Alberta, Canada. sgilmour@capitalhealth.ca

Insights

Pediatric liver transplant recipients often experience cognitive delays. This study found that pretransplant growth issues and calcineurin inhibitor levels impact intelligence quotient (IQ) in these children.

Area of Science:

  • Pediatric Gastroenterology
  • Neuroscience
  • Transplant Surgery

Background:

  • Outcomes research in pediatric liver transplant (LT) traditionally emphasizes mortality and morbidity.
  • There is a critical need to evaluate functional outcomes, specifically cognitive development, in pediatric LT survivors.

Purpose of the Study:

  • To assess cognitive function in children following liver transplantation for infantile chronic liver disease.
  • To identify patient variables associated with cognitive delay or borderline delay post-LT.

Main Methods:

  • Administered standardized cognitive testing (Bayley Scales or Wechsler) to 30 transplanted children.
  • Analyzed patient variables using multiple regression to determine associations with cognitive scores.
  • Examined relationships between pretransplant factors, medication levels, and cognitive outcomes (VIQ/PIQ).

Main Results:

  • Mean developmental quotient/intelligence quotient (DQ/IQ) was 81 +/- 17.
  • 27% of children showed cognitive delay (DQ/IQ < 70) and 27% borderline delay (DQ/IQ 70-84).
  • Pretransplant growth retardation and elevated calcineurin inhibitor levels were associated with decreased IQ; elevated ammonia correlated with lower Performance IQ.

Conclusions:

  • Children post-liver transplant are at significant risk for cognitive delay or borderline delay.
  • This study is the first to link calcineurin inhibitors to impaired IQ in pediatric LT recipients.
  • Different variables predict impaired verbal versus performance intelligence quotients, highlighting distinct neurodevelopmental impacts.

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...